Comparing Three Profoundly Influential Prognostic Scores in Cirrhotic Patients with Acute-on-Chronic-Liver Failure Admitted to the ICU: Prediction of One-Month Mortality-A Retrospective Cohort Study.
Shih-Hua LinWei-Ting ChenMing-Hung TsaiWei-Liang KuoSheng-Fu WangYu LiuYu-Ting ChiuBo-Huan ChenChien-Hao HuangRong-Nan ChienPublished in: Diagnostics (Basel, Switzerland) (2023)
In critically ill cirrhotic patients with ACLF admitted to the hepatology ICU, CLIF ACLF-lactate outperformed CLIF-C ACLF and NACSELD-ACLF in predicting one-month mortality. Nevertheless, no statistically significant difference was observed between CLIF-C ACLF and CLIF-C ACLF lactate. Larger-scale multi-center prospective studies are warranted to validate these results.